title: Greenhouse and field cultivations of antigen-expressing potatoes focusing on the variability in plant constituents and antigen expression.
abstract: The production of plant-derived pharmaceuticals essentially requires stable concentrations of plant constituents, especially recombinant proteins; nonetheless, soil and seasonal variations might drastically interfere with this stability. In addition, variability might depend on the plant organ used for production. Therefore, we investigated the variability in plant constituents and antigen expression in potato plants under greenhouse and field growth conditions and in leaves compared to tubers. Using potatoes expressing VP60, the only structural capsid protein of the rabbit haemorrhagic disease virus (RHDV), CTB, the non-toxic B subunit (CTB) of the cholera toxin (CTA-CTB(5)) and the marker protein NPTII (neomycinphosphotransferase) as a model, we compare greenhouse and field production of potato-derived antigens. The influence of the production organ turned out to be transgene specific. In general, yield, plant quality and transgene expression levels in the field were higher than or similar to those observed in the greenhouse. The variation (CV) of major plant constituents and the amount of transgene-encoded protein was not influenced by the higher variation of soil properties observed in the field. Amazingly, for specific events, the variability in the model protein concentrations was often lower under field than under greenhouse conditions. The changes in gene expression under environmental stress conditions in the field observed in another event do not reduce the positive influence on variability since events like these should excluded from production. Hence, it can be concluded that for specific applications, field production of transgenic plants producing pharmaceuticals is superior to greenhouse production, even concerning the stability of transgene expression over different years. On the basis of our results, we expect equal or even higher expression levels with lower variability of recombinant pharmaceuticals in the field compared to greenhouse production combined with approximately 10 times higher tuber yield in the field.
authors: Agrobiotechnologie, Universität Rostock, Justus-von-Liebig-Weg 8, Rostock, Germany. Heike.Mikschofsky@uni-rostock.de
authors: Heike
authors: H
authors: Mikschofsky
authors: Elena
authors: E
authors: Heilmann
authors: Jörg
authors: J
authors: Schmidtke
authors: Kerstin
authors: K
authors: Schmidt
authors: Udo
authors: U
authors: Meyer
authors: Peter
authors: P
authors: Leinweber
authors: Inge
authors: I
authors: Broer
references: Environ Biosafety Res. 2004 Apr-Jun;3(2):99-107
references: 15612507
references: Plant Mol Biol. 2003 May;52(1):217-31
references: 12825701
references: Mol Gen Genet. 1992 Nov;235(2-3):389-96
references: 1465111
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: Biotechnol Adv. 2009 Nov-Dec;27(6):1015-1022
references: 19460423
references: J Virol. 1990 Jul;64(7):3331-6
references: 2352325
references: Mol Gen Genet. 1995 Oct 25;248(6):649-56
references: 7476867
references: J Virol. 1990 Aug;64(8):4013-5
references: 2164609
references: Biotechnol Bioeng. 2009 Mar 1;102(4):1182-96
references: 18979540
references: Int J Mol Sci. 2009 Jul 10;10(7):3168-85
references: 19742130
references: Curr Opin Plant Biol. 2010 Apr;13(2):219-25
references: 20022290
references: BMC Biotechnol. 2002 Apr 04;2:4
references: 11934354
references: APMIS. 2000 Mar;108(3):178-86
references: 10752686
references: Transgenic Res. 2001 Jun;10(3):223-36
references: 11437279
references: Biotechnol Adv. 2009 Nov-Dec;27(6):879-894
references: 19647060
references: Plant Biotechnol J. 2009 Dec;7(9):883-98
references: 19843250
references: Plant Mol Biol. 1991 Jul;17(1):49-60
references: 1907871
references: Plant Biotechnol J. 2009 Aug;7(6):537-49
references: 19486322
references: Virology. 1991 Oct;184(2):664-76
references: 1840711
references: Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11745-9
references: 1465391
references: Science. 1985 Mar 8;227(4691):1229-31
references: 17757866
references: Nature. 2004 Nov 11;432(7014):222-5
references: 15538370
references: Cell Mol Life Sci. 2004 Oct;61(19-20):2632-45
references: 15526168
references: Vaccine. 2005 Sep 15;23(39):4734-44
references: 15955601
references: Plant Biotechnol J. 2007 Jul;5(4):511-25
references: 17490449
references: Anal Biochem. 1987 May 15;163(1):16-20
references: 2441623
references: J Virol. 1999 May;73(5):4452-5
references: 10196345
references: Mol Gen Genet. 1992 Nov;235(2-3):189-96
references: 1465092
references: Vaccine. 2005 Mar 7;23(15):1764-9
references: 15734038
references: Arch Virol. 1999;144(4):719-35
references: 10365163
references: Plant Physiol. 1997 Nov;115(3):939-47
references: 9390430
references: Nucleic Acids Res. 1980 Oct 10;8(19):4321-5
references: 7433111
references: Virology. 2001 Feb 15;280(2):283-91
references: 11162842